BPC-157 Peptide 5mg

BPC-157 Peptide 5mg: Product Overview

BPC-157 Peptide 5mg, also known as Body Protection Compound-157 or Bepecin, is a synthetic pentadecapeptide investigated in experimental studies of cellular signaling, gastrointestinal tissue biology, and tissue repair mechanisms.

Composed of 15 amino acids, BPC-157 has attracted scientific interest for its activity in preclinical models involving connective tissues, blood vessel formation, and cellular responses to injury.

Unlike growth hormone secretagogues such as GHRP-2 and Ipamorelin, BPC-157 belongs to a different peptide research category. The 5mg designation identifies the stated peptide quantity in this product listing.

BPC-157 5mg Product Specifications

• Product Name: BPC-157 Peptide 5mg
• Alternative Names: BPC 157, Body Protection Compound-157, Bepecin
• Peptide Type: Synthetic pentadecapeptide
• Peptide Length: 15 amino acids
• Peptide Sequence: GEPPPGKPADDAGLV
• CAS Number: 137525-51-0 (free peptide)
• Molecular Formula: C62H98N16O22 (free peptide)
• Molecular Weight: Approximately 1419.5 g/mol
• Listed Quantity: 5mg
• Research Category: Cellular Signaling and Tissue Biology
• Product Category: Research Peptides

These molecular specifications refer to the free-peptide form of BPC-157. BPC-157 acetate and other preparations can have different compositional characteristics. The supplied chemical form should be verified using product-specific documentation.

What Is BPC-157 Peptide?

BPC-157 is a synthetic peptide composed of 15 amino acid residues. Its sequence is associated with research into gastric-derived protective compounds and biological processes involved in tissue responses to injury.

Experimental investigations have examined BPC-157 in models involving gastrointestinal tissues, tendons, ligaments, muscles, and vascular signaling.

Although these studies have produced interesting preclinical findings, BPC-157 remains investigational, and its effectiveness in humans has not been established.

Key Characteristics of BPC-157

• Defined Peptide Structure: A synthetic 15-amino-acid sequence with established chemical reference characteristics.
• Tissue Biology Research: Studied in preclinical models involving connective tissue responses and tissue repair pathways.
• Gastrointestinal Research: Investigated in experimental models of gastric and intestinal tissue responses.
• Cellular Signaling: Research has explored interactions involving growth factor pathways and cellular migration.
• Vascular Research: Investigated for effects on blood vessel-related signaling in experimental models.
• 5mg Presentation: Clearly identified peptide quantity for laboratory research documentation.

BPC-157 Mechanism of Action

The biological mechanisms associated with BPC-157 remain under investigation. Preclinical research has examined potential interactions involving nitric oxide signaling, angiogenesis, growth factor-related pathways, and cellular migration.

Some animal and laboratory studies have reported changes in biological processes associated with tissue repair after exposure to BPC-157.

However, no single established mechanism fully explains the reported experimental effects. Findings in laboratory and animal models cannot automatically be translated into clinical benefits in humans.

BPC-157 and Tissue Repair Research

BPC-157 has been investigated in experimental studies involving tendon, ligament, muscle, and other connective tissue models.

Researchers have explored cellular migration, collagen-related responses, and biological processes involved in tissue organization after injury.

These investigations are primarily preclinical. Current human research is insufficient to establish BPC-157 as a proven treatment for sports injuries, tendon damage, or muscle recovery.

BPC-157 and Gastrointestinal Research

Early investigations of BPC-157 focused on gastrointestinal tissue biology and protective responses in experimental models.

Animal studies have evaluated the peptide in models involving gastric lesions, intestinal tissue integrity, and inflammatory processes.

These findings contributed to scientific interest in BPC-157, but they do not establish clinical effectiveness for gastrointestinal diseases in humans.

BPC-157 vs TB-500: Key Differences

BPC-157 and TB-500 are frequently discussed together in peptide research, but they represent different molecular structures and research backgrounds.

• BPC-157: A synthetic pentadecapeptide investigated in experimental models of gastrointestinal tissue biology and connective tissue responses.
• TB-500: A peptide associated with the thymosin beta-4 research family, commonly identified with a shorter synthetic peptide fragment.
• Molecular Structure: BPC-157 contains 15 amino acid residues, while commonly described TB-500 fragment preparations have a different sequence and structure.
• Research Evidence: Findings involving these compounds should be evaluated individually rather than treated as interchangeable.

Commercial naming conventions for TB-500 can vary. Accurate comparisons require confirmation of the supplied peptide identities and sequences.

BPC-157 vs Growth Hormone Peptides

BPC-157 differs from growth hormone secretagogues such as GHRP-2, GHRP-6, and Ipamorelin.

Growth hormone secretagogues interact with receptor systems associated with endogenous growth hormone secretion. BPC-157 has instead been investigated primarily in experimental tissue biology and cellular signaling research.

BPC-157 should not be described as recombinant human growth hormone or as a growth hormone secretagogue.

BPC-157 Scientific Research Background

Scientific investigations of BPC-157 have included experimental studies involving connective tissues, gastrointestinal systems, vascular signaling, and cellular responses to injury.

Many published findings come from laboratory and animal models. Human evidence remains limited to small, methodologically weak studies, with insufficient data to establish reliable clinical effectiveness or long-term safety.

Further controlled human research is needed to clarify its biological effects, pharmacological properties, and clinical relevance.

BPC-157 Peptide 5mg Product Documentation

The BPC-157 Peptide 5mg product listing identifies a stated quantity of synthetic peptide material.

Product evaluation should include verification of the amino acid sequence, chemical form, declared quantity, original labeling, and available batch-specific analytical documentation.

Relevant documentation may include peptide identity analysis, purity testing, and formulation-specific storage instructions. Reference chemical properties do not establish the quality of an individual supplied batch.

BPC-157 remains an investigational compound, and its safety and effectiveness for human use have not been established.